Introduction
Studies designed to explore pathogenicity in citrus exocortis viroid (CEVd) and potato spindle tuber viroid (PSTVd) have implicated the pathogenic (P) domain as the principal site for control of symptom severity (Schnolzer et al., 1985 ; Gora et al., 1996 ; Owens et al., 1995 Owens et al., , 1996 . Interspecific viroid constructs from CEVd and tomato apical stunt viroid (TASVd) further suggested that both the terminal left (TL) as well as the variable (V)jterminal right (TR) domains may also influence the severity of symptoms (Sano et al., 1992) . Also, the V domain could not exclusively be correlated with pathogenicity in PSTVd (Gora et al., 1996) or CEVd (Visvader & Symons, 1986) . With PSTVd infection, a simple correlation of concentration of the viroid variant with pathogenicity could not be established (Gruner et al ., 1995) and chimeras between CEVd and hop stunt viroid (HSVd) implicated the TR domain in viroid replication or accumulation without affecting symptoms (Sano & Ishiguro, 1998) .
From the highly conserved genome within the HSVd group (Sano et al., 1989) and the stability of variant populations among diverse natural hosts (Kofalvi et al., 1997) , it may be conjectured that biological activity might be focused in a welldefined site of the viroid genome. Citrus viroids (CVd) have been classified on the basis of physical and biological properties into five groups (Duran-Vila et al., 1988 ; Semancik & DuranVila, 1991) with Group II comprising HSVd-related viroids. Citrus cachexia viroid (CCaVd) (Semancik et al., 1988) , the causal agent of cachexia disease of citrus (Childs, 1950 (Childs, , 1952 , has been catalogued as CVd-IIb and the closely related CVdIIa has been described as a non-cachexia-inducing variant. These two viroids are very similar in size, 302 nt (CVd-IIa) and 299 nt (CVd-IIb), and share a sequence identity of 98 % (Levy & Hadidi, 1992) , which reinforces the proposition that cachexia pathogenicity might be controlled by a concise sequence in the genome. Differential biological activity between the two HSVdrelated CVd variants (-IIa and -IIb) can be monitored by symptom severity in cucurbit hosts (Shikata, 1990) as well as mandarin, an indexing host for the cachexia disease, which reacts only to CVd-IIb (Roistacher et al., 1973) . These dual biological response systems employing a woody perennial and a herbaceous annual host from distinct botanical families provide a novel approach for testing the correlation of pathogenicity with structural domains in a quantitative (Luffa) as well as qualitative (mandarin) manner.
This report presents data defining : (1) the physical and biological properties of variants of CVd-II investigated here, (2) the biological activity associated with chimeric viroid cDNA constructs between CVd-IIa and CVd-IIb, and (3) a proposed locus for induction of a severe pathogenic reaction in Luffa by CVd-IIa and in mandarin by CVd-IIb within the V domain of each viroid.
Methods
Viroid determination. Citron (Citrus medica L.) tissues infected with either CVd-IIa (Semancik et al., 1997) or CVd-IIb (Francis et al., 1995) were extracted as reported by Semancik et al. (1988) . Nucleic acid preparations enriched for viroids were analysed by sequential polyacrylamide gel electrophoresis (sPAGE) and silver-stained to determine the viroid profile and titre. Partially purified viroids were amplified by RT-PCR (Sambrook et al., 1989) using two pairs of primers for CVd-II variants, cDNA625\hDNA1394 (72-88\89-106) of the central domain and IICI\IIHI (271-288\283-302) (Fig. 1 a) , and sequenced by the dideoxy termination technique (Sanger et al., 1977 (Sanger et al., , 1980 using the Promega ' fmol ' system. Viroid cDNA clones. Full-length viroid cDNA of CVd-IIa and CVd-IIb was amplified by RT-PCR using the IICI and IIHI primers. After phenol purification, the PCR products were cut with BamHI and ligated into the dephosphorylated plasmid SP72 followed by transformation to E. coli strain DH5α prepared by the method described by Cohen et al. (1972) . These were designated as clone-IIa and clone-IIb.
Chimeric viroid cDNA clones. The viroid cDNA clones were digested with the restriction endonucleases BamHI, SmaI and HgaI at the sites indicated in Fig. 1 (b) . Fragments (1) BamHI-SmaI, (2) SmaI-HgaI and (3) HgaI-BamHI from clone-IIa and clone-IIb were reciprocally exchanged and ligated into plasmid SP72. The six resulting full-length chimeric cDNA clones, designated CM1-CM6 (Fig. 2) , were sequenced using T7 and SP6 primers to verify the fidelity of fragment ligation and nucleotide composition.
Site-directed mutagenesis. By designing primers containing altered sequences to CVd-IIa at specific positions, nucleotide sequences found in CVd-IIb and not in CVd-IIa were introduced into clone-IIa by PCR as described by Stappert (1994) and Tao & Lee (1994) . Oligonucleotide primer IIBh (5h CGGGGCAACTCTTCTCAGAATCCAGC-GGGGGCGTGGAGGG 3h) was designed to mutate clone-IIa at positions A107 (A G), A109 (A kA) and A115 (A kA) while primer IIBc (5h ACCGGTCGCGTCTCACTCGAAGAGCCAGAAG-GAGGTAAAGAA 3h) was designed to mutate at positions U188 (U kU), U193 (U C, and C196 (C U) (Fig. 1) . The three sitedirected mutagenic cDNA clones thus derived were designated : (1) SM1 (mutated at position A107, A109 and A115), SM2 (mutated at positions U188, U193 and C196) and (3) SM3 (mutated at the sites of both SM1 and SM2).
Bioassay of viroid cDNA clones. Dimeric viroid cDNA clones have been reported to be superior to RNA transcripts as a source of inoculum (Cress et al., 1983 ; Ishikawa et al., 1984 ; Meshi et al., 1985) . Therefore, monomeric viroid cDNA clones were dimerized as described in Sambrook et al. (1989) and cloned into plasmid SP72. After transforming to E. coli, nucleotide sequence determination confirmed the presence of the viroid cDNA plus-strand ligated downstream from the T7 promoter . The dimeric cDNA clones were digested with HindIII and resuspended in autoclaved distilled water after phenol purification and ethanol precipitation. These preparations were used as the templates for RNA transcription using the MEGAscript in vitro transcription kit (Ambion). It was found later, however, that both monomeric and dimeric cDNA could also be employed as an inoculum source.
The parental viroids as well as the viroid cDNA clones and constructs were bioassayed on the woody systemic host Parson's special mandarin as a specific cachexia disease bioassay and on Luffa aegyptiaca Mill. as a more general herbaceous cucurbit indicator for HSVd-related viroids.
Structural analysis by computer modelling. Viroid sequences were compared for similarity using the GAP program in the GCG Sequence Package (Genetics Computer Group, 1994 ) at a gap-weight of 5 and a gap-length-weight of 0n3. Modelling of minimum free energy and related suboptimal structural forms for viroid and construct sequences was carried out using the MFold program in GCG designed for circular single-stranded RNA molecules (Zuker, 1989) .
Results

Nucleotide sequence of CVd-IIa and CVd-IIb and derived cDNA clones
The nucleotide sequence of CVd-IIa, the non-cachexiainducing variant, was as reported by Semancik et al. (1997) , while a number of differences were detected from the previous reports (Levy & Hadidi, 1992 ; Francis et al., 1995) in the sequences of the cachexia-inducing variant (CVd-IIb). The principal distinction found here between CVd-IIa and CVd-IIb was a cluster of eight changes concentrated in the region bordering the conserved and variable domains (Fig. 1 b) . Five additional changes were scattered in the molecule with two changes each detected in the P and T1 domains and one in the T2 domain.
From this analysis, the V domain was targeted as the region most probably governing the principal difference in biological activity between these two closely related viroids, the induction of cachexia disease by CVd-IIb. This supposition was supported by the detection of the same six-nucleotide cluster change in two other cachexia-inducing isolates, CVd-IIc and Ca-903 (unpublished data). RT-PCR products from CVd-IIa (302 nt) and CVd-IIb (299 nt) were cloned with fidelity into plasmid SP72 with the exception of a single change (U180 G) detected in clone-IIa, which was demonstrated not to alter the biological activity of CVd-IIa. Chimeric viroid cDNA clones (Fig. 2) constructed by reciprocal exchanges between clone-IIa and clone-IIb restriction fragments (Fig. 1 b) displayed the expected sequence of the constituent restriction fragments. Site-directed mutations introduced into clone-IIa (Fig. 1 b) contained point mutations at positions in the V domain which had been targeted as common to cachexia-inducing viroids. The SM1-clone introduced three nucleotide changes in the upper V domain in clone-IIa, the SM2-clone contained three changes in the lower V domain, and the SM3-clone incorporated the combined changes in the six positions identified as SM1 and SM2.
Progeny viroids were analysed from both citron and Luffa following inoculation with the parental cDNA clones as well as the chimeric and site-directed mutant constructs. The viroid titre as estimated by sPAGE band intensity and nucleotide sequence remained unchanged for infection by clone-IIa and clone-IIb (Table 1) . Although the progeny from inoculation of the chimeric and site-mutated constructs to citron retained a similar titre and sequence stability with only two nucleotide changes detected, several changes were detected in the progeny from Luffa inoculated with the CM4, SM2 and SM3 constructs. The changes in the SM2 and SM3 constructs represented reversions of the targeted sites for mutation in Luffa which were otherwise stable in progeny viroid recovered from citron.
Infectivity of viroid cDNA clones and RNA transcripts
The two bioassay systems employed, Luffa aegyptiaca and Parson's special mandarin (PSM), differentiated reciprocally in both a quantitative and a qualitative manner with respect to biological activity of CVd-IIa and CVd-IIb. A visually more severe reaction in Luffa was induced by CVd-IIa (Fig. 3 a) compared with CVd-IIb (Fig. 3 b) , while PSM has been shown to respond with symptoms characteristic of a cachexiainducing isolate only to CVd-IIb. Symptoms on Luffa appeared in the new tissue flush produced after the first cut-back of the apex tissue 1 month post-inoculation. Severe symptoms of short internodes and dwarfed leaves with rugous lamina appearing on Luffa after inoculation with clone-IIa were identical to those induced by CVd-IIa. In contrast, infection by clone-IIb resulted in a significantly milder reaction on Luffa typical of CVd-IIb (Table  2) .
The PSM bioassay for the cachexia disease is more problematic, not only in the long length of the incubation interval but also in the intensity of the pitting and gumming response in different experiments. Nevertheless, the test is extremely valuable in indexing for cachexia disease and has been reliable in providing a consistent positive reaction for CVd-IIb and a negative response for CVd-IIa. The same differential quantitative reaction was also observed here with inoculation of clone-IIa and clone-IIb (Table 2) .
Altered biological activity introduced by chimeric and site-mutated cDNA clones
Luffa. Three of the chimeric viroid cDNA clones induced severe-moderate symptoms in Luffa similar to those induced by CVd-IIa and clone-IIa (Table 2) . These chimeras were characterized by a common C-V-T2 domains region from clone-IIa contained in different restriction fragments : CM1 (SmaI-HgaI), CM3 (SmaI-BamHI) and CM5 (BamHI-HgaI) (Fig. 2) . The reciprocal chimeric cDNA clones, CM2, CM4 and CM6, containing the identical C-V-T2 region from the cloneIIb genome, induced only mild symptoms in Luffa similar to those of CVd-IIb. Site-directed mutated cDNA clones were designed to introduce changes in clone-IIa at specific loci in the V domain as contained in the CVd-IIb sequence. In doing so, expression of all symptoms induced by SM clones in Luffa was reduced to a more mild condition than observed following inoculation with clone-IIa (Table 2 ).
Parson's special mandarin. Chimeric cDNA clones, CM1, CM3, and CM5, induced no cachexia reaction in PSM. However, the reciprocal paired constructs CM2 and CM4, with the same genomic region from clone-IIb, induced strong cachexia symptoms. Even though the CM6 variant comprised the largest portion of the CVd-IIb genome combined with the HgaI-BamHI insert of clone-IIa, a cachexia-positive reaction was not observed. In addition, the CM6 construct contained the same CVd-IIb component as the CM2 construct, which registered a cachexia-positive index.
The site-directed mutated cDNA clones SM1 and SM2, containing only three nucleotide changes each in the upper and lower V domain of clone-IIa, induced no discernible symptom reaction on PSM (Table 2) . However, when the entire sixnucleotide cluster in CVd-IIa was converted to a CVd-IIb configuration (SM3), demonstrable symptoms were observed similar to CVd-IIb. The definitive symptoms expressed by PSM provided strong evidence for the acquisition of cachexia infectivity in mandarin by clone-IIa when mutated in the V domain targeted sites.
Structural properties of CVd-IIa, CVd-IIb and derived constructs
The unusual feature of the viroid as a non-translatable, transmissible RNA has established the importance of secondary structure for replication and pathogenesis in this unique class of conformational pathogen. From this, structural features of the source viroids as well as the chimeric constructs and sitemutated variants were analysed by the MFold program to determine the number and energy range predicted for the suboptimal molecular models.
Two characteristically different patterns emerged for the number of suboptimal forms predicted between CVd-IIa with two structural forms and CVd-IIb with six (Table 3) . Among the chimeric constructs, an interesting correlation was observed between the number of suboptimal forms and biological activity. The three constructs, CM1, CM3 and CM5, containing the common C-V-T2 domains region of CVd-IIa, displayed two structural forms similar to the full-length CVdIIa. In contrast, the three constructs, CM2, CM4 and CM6, containing the C-V-T2 domains region from CVd-IIb, were characterized by a larger number (five to eight) of structural forms.
The subtle changes introduced into the CVd-IIa genome by the three to six nucleotide modifications in the V domain resulted in a dramatic alteration in the number of suboptimal forms predicted by the MFold program. In contrast to the two structural forms of clone-IIa, the SM constructs had five to six predicted suboptimal molecular forms, more similar to CVdIIb.
Discussion
Molecular properties of HSVd-related citrus viroids
Although some sequence variations have been found clustered in the P and V domains of HSVd variants (Sano et al., 1989) , similar to PSTVd and CEVd (Herold et al., 1992 ; Gora et al., 1994) , identity within the HSVd group in excess of 93 % is unusually high. The HSVd genome is remarkably stable across a broad host range and does not display host adaptation (Kofalvi et al., 1997) as in the case of CEVd (Semancik et al., 1993) . This observation is further supported by the passage of CVd-IIb, as an HSVd-related CVd, through hosts in five different botanical families with evidence of only one or two nucleotide exchanges (Reanwarakorn, 1997) .
A similar stability of nucleotide sequence in the progeny viroids resulted when citron and Luffa were inoculated with clone-IIa and clone-IIb. However, a more variable profile in progeny sequence followed inoculation of chimeric constructs. Although viroid progeny from citron was highly conserved, a number of changes were introduced with replication in Luffa.
Citron progeny displayed only single nucleotide changes in CM1 and SM1 ; however, these changes remained stable in CM3 and SM2 with similar biological activity.
Viroid progeny recovered from Luffa registered a single change into CM2 and four into CM4. All of these changes occurred in either the T1 or the P domain portion of the IIaderived sequence without inducing the severe symptoms which were associated with the C-V-T2 domains segment. However, changes introduced into SM2 and SM3 by replication in Luffa represented reversions of the mutation site to the parental clone-IIa sequence. Thus, the viroid progeny from Luffa inoculated with either SM2 or SM3 contained the same single change, C196 U. The single change in SM1 (G108 A) was not a targeted position.
A CEVd variant found to be highly stable in both sweet orange and citron displayed a pattern of host selection when inoculated to gynura and tomato (Semancik et al., 1993) and other herbaceous hosts (Fagoaga et al., 1995) . In contrast, the apparent stability of the parental CVd-II clones would suggest that some of the chimeric constructs as well as the site-mutated variants might introduce a less stable molecular conformation.
Biological activity associated with viroid constructs
Luffa can be exploited for quantitative symptom expression exemplifying the biological difference between CVd-IIa and CVd-IIb. With the PSM indexing host for cachexia, biological activity is much more definitive and qualitative since only CVd-IIb is competent to induce symptoms. Both plant species were employed to track the specificity of pathogenicity in different viroid-host interactions.
Chimeric constructs (CM1-6). The severe symptom reaction of both Luffa and PSM to constructs containing the C-V-T2 domains section of either CVd-IIa or CVd-IIb, respectively, points to this general locus for pathogenicity in the genome of CVd-II viroids. Since the CM constructs comprise a series of three reciprocal pairs, it is possible to review the biological activity in this manner to develop a more general pattern.
The CM1 and CM2 chimeric pair containing the C-V-T2 domains section of CVd-IIa and CVd-IIb, respectively, induced severe and mild symptom responses on Luffa characteristic of the parent viroids as well as the derived clone-IIa and -IIb. Even more striking were the severe symptoms on PSM observed with the CM2 construct containing the C-V-T2 domains section (SmaI-HgaI) of CVd-IIb, while inoculation with the CM1 variant produced no symptoms. A similar inverse relationship of biological activity is reinforced by the second pair of reciprocal constructs, CM3 and CM4, which carry the lower P domain (HgaI-BamHI) in addition to the C-V-T2 domains segment contained in CM1 and CM2.
The third reciprocal pair, CM5 and CM6, however, presented a less definitive biological response. Although CM5, constructed from the largest portion of clone-IIa, induced moderate symptoms on Luffa, CM6, containing the largest part of the CVd-IIb genome, did not induce the expected symptoms on PSM. In addition to the obvious possibility of technical problems associated with an extended systemic bioassay in a woody plant species, an alternative explanation of this inconsistency might indicate that control of symptom expression in PSM was governed not by the specific genome sequence contained within the SmaI-HgaI segment of CVd-IIb, but rather by the ultimate structure and conformation determined by the entire sequence.
Nevertheless, two of the three experimental pairs of reciprocal constructs provide reinforcing and strongly supportive evidence to localize the association of pathogenicity for both Luffa and PSM to the C-V-T2 domains region of CVdIIa and CVd-IIb, respectively.
Site-mutants (SM1-3). Alteration of the basic clone-IIa sequence by only three (SM1 and SM2) nucleotides in the upper and lower V domain did not change the PSM reaction from the initial clone. However, the combination of both sets of nucleotide changes in the SM3 construct resulted in the dramatic acquisition of severe pathogenicity to PSM by the site-mutated clone-IIa. These site-mutated changes were also accompanied by a reduction in severe symptom expression in Luffa. However, the sequence reversions detected in progeny from Luffa inoculated with SM2 and SM3 resulted in an identical variant with a single change, C196 U. This suggests that changes introduced into either the nt 107-115 upper V site or at nt 196 might produce an equivalent effect on Luffa. The qualitative infectivity provided by PSM permits an even finer definition of the site for pathogenicity to the sixnucleotide cluster within the V domain. The quandary remains as to whether the inoculating variant or the resulting progeny population were the prime agents for induction of symptoms. The data support the view that control of pathogenicity in Luffa and PSM is focused in the variable domain.
Correlation between biological activity and suboptimal molecular structures
Evaluation of the number and energy range of the suboptimal molecular forms predicted for CVd-IIa and CVd-IIb might provide parameters for the correlation of biological activity distinctions between the sequences of such closely related molecular species. With the MFold program, a remarkable distinction in the number of suboptimal molecular forms was predicted with two for CVd-IIa in contrast to six for CVd-IIb.
The chimeric constructs CM1, CM3 and CM5, containing in common the C-V-T2 domains segment (SmaI-HgaI) from CVd-IIa, had the same number of suboptimal forms and relative stability as CVd-IIa. This direct correlation of physical properties between CVd-IIa and the chimeric constructs was reinforced by the demonstration of common biological activity.
Similarly, CM2, CM4 and CM6, sharing in common the C-V-T2 domains segment (SmaI-HgaI) from CVd-IIb, reflected the larger number (five to eight) of suboptimal forms as for CVd-IIb and clone-IIb. These same chimeric constructs displayed similar reduced infectivity to Luffa and acquisition of PSM pathogenicity (CM2 and CM4) as the source CVd-IIb. The large number (five or six) of suboptimals introduced by three (SM1, SM2) to six (SM3) nucleotide exchanges into the CVd-IIa genome speak to the importance of the six-nucleotide cluster in the V domain in defining a structural similarity to CVd-IIb. Although this correlation is further strengthened by the mild symptoms induced on Luffa, the induction of symptoms by the SM3 construct only indicates that a simple direct relationship cannot be fully extended to the cachexia indicator host PSM, and that even with an increase in the number of predicted suboptimal structures, the biologically active form was not achieved.
A consistent pattern has emerged for the control of pathogenicity for Luffa and PSM by a locus in the V domain of both CVd-IIa and CVd-IIb. A cluster defined within the V domain was further identified by the subtle changes introduced by the site-directed variants. Since the P domain has been consistently demonstrated as the site of pathogenicity for tomato in PSTVd (Schnolzer et al., 1985 ; Owens et al., 1996 ; Gora et al., 1996) , the apparent contrast in the data presented here may be a reflection of distinctions in different viroid groups as well as plant species employed as the assay systems. Alternatively, the mutations introduced into the VM region of the P domain may simply function to bring about alterations in the structure of the molecule as a whole as suggested by Gruner et al. (1995) , thus modifying biological activity.
Evidence presented here suggests a pre-eminent role for the genome segment contained in the V domain for control of pathogenesis by HSVd-related CVds. In addition, the correlation of structural features introduced by differential suboptimal molecular forms with biological activity in two host systems extends the relationship between hosts and viroids as conformational pathogens.
